BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Metformin: trial readouts and FDA decisions

1 upcoming industry Phase 2/3 readout(s) in the next 90 days, 0 upcoming FDA event(s), 4 readout(s) in the last 180 days and 0 FDA event(s) in the last 12 months. Sponsors: Celltrion, CSPC Ouyi Pharmaceutical Co., Ltd., Dexa Medica Group, Beijing Dongfang Biotech Co., Ltd., EMS. Drug names come from ClinicalTrials.gov intervention names and FDA records, lightly normalised; one drug can appear under several names (code, generic, brand).

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P3CelltrionNCT07093476 Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and MetforminT2DM; Diabete Type 2; DMrecruiting171

Readouts, last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-10-30 est.P3CSPC Ouyi Pharmaceutical Co., Ltd.NCT07026968 A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 DiabetesType 2 Diabetesactive not recruiting815
2026-10-15P3Dexa Medica GroupNCT07937449 The Efficacy and Safety of DLBS3233 in Adults With PrediabetesPrediabetescompleted120
2026-10-01 est.P3Beijing Dongfang Biotech Co., Ltd.NCT06257966 A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With MetforminType2 Diabetes Mellitusactive not recruiting600
2026-07 est.P3EMSNCT04670666 Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes MellitusType 2 Diabetes Mellitusrecruiting270

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.